|Bid||56.00 x 800|
|Ask||60.22 x 800|
|Day's Range||58.06 - 60.21|
|52 Week Range||20.81 - 79.50|
|Beta (5Y Monthly)||1.38|
|PE Ratio (TTM)||187.34|
|Earnings Date||Dec 08, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jan 16, 2020|
|1y Target Est||64.75|
CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its first quarter ended October 31, 2020 on Tuesday, December 8, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.
Cantel (CMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Due to the coronavirus pandemic, it would seem that stocks of infection control companies are no-brainer investments, but it's not that simple. While companies and healthcare facilities have become more vigilant when it comes to preventing disease, the pandemic has also considerably slowed business for some clients of infection control businesses. While hospitals are being even more careful about infection control, fewer people are visiting their physicians and dentists, so infection control business from those industries has also fallen.